LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.56234
5.36 27.76 1 320 0.0031 -0.6101
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
5.36 27.76 832 320 2.5971 1.6212
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
7.06 27.76 5 360 0.0139 -0.3710
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
7.06 27.76 898 360 2.4944 1.5610
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
7.06 27.76 1 360 0.0028 -0.5930
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
7.06 27.76 854 360 2.3722 1.5264
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
8.76 27.76 8 401 0.0199 -0.2759
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
8.76 27.76 948 401 2.3632 1.5002
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
8.76 27.76 2 401 0.0050 -0.4947
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
8.76 27.76 923 401 2.3009 1.4829
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
10.46 27.76 96 438 0.2189 0.3656
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
10.46 27.76 1020 438 2.3254 1.4721
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
10.46 27.76 4 438 0.0091 -0.3852
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
10.46 27.76 1013 438 2.3094 1.4678
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
12.17 27.76 434 489 0.8874 0.9431
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
12.17 27.76 1086 489 2.2205 1.4251
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
12.17 27.76 6 489 0.0123 -0.3093
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
12.17 27.76 979 489 2.0018 1.3651
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
13.87 27.76 833 604 1.3775 1.1494
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
13.87 27.76 1137 604 1.8802 1.3052
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
13.87 27.76 8 604 0.0132 -0.2441
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
13.87 27.76 1073 604 1.7744 1.2754
MN20160318_Q01
L13
MCF 10A-H2B-mCherry Neratinib
0.56234
15.58 27.76 929 685 1.3551 1.1358
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
15.58 27.76 1086 685 1.5841 1.2091
MN20160318_Q01
L11
MCF 10A-H2B-mCherry Neratinib
0.56234
15.58 27.76 8 685 0.0117 -0.2358
MN20160318_Q01
L13